Company Overview and News

 
Bluechiip: Access latest PPT from Proactive's CEO Sessions

2017-03-17 proactiveinvestors.com.au
Bluechiip's (ASX:BCT) managing director, Andrew McLellan, joined Proactive's CEO Sessions in Sydney on Tuesday 14th March and Melbourne on Wednesday 15th March.
Upvote Downvote

 
Cobalt Blue to outline resource growth strategy at Proactive's CEO Sessions

2017-03-10 proactiveinvestors.com.au
Cobalt Blue Holdings (ASX:COB) was only recently minted on the ASX, yet the company has already outlined a rapid growth story.
Upvote Downvote

 
White Cliff Minerals brings gold, lithium, nickel to Proactive's CEO Sessions

2017-03-10 proactiveinvestors.com.au
White Cliff Minerals (ASX:WCN) has near-term gold production potential, and is currently working towards a new JORC Resource for the high-grade Aucu gold project located in the Kyrgyz Republic of central Asia.
Upvote Downvote

 
Bluechiip brings wireless tracking technology to Proactive's CEO Sessions

2017-03-08 proactiveinvestors.com.au
Bluechiip (ASX:BCT) has developed an IT based temperature and identification tracking solution for biosamples in the health and life sciences industry.
Upvote Downvote

 
Proactive's CEO Spotlight Sessions: Cynata, Bluechiip, White Cliff, Legend Mining

2017-03-07 proactiveinvestors.com.au
These events are tailor-made for private and professional investors who have exposure to equities, particularly growth stocks - or indeed anyone who is considering putting their money to work in dynamic sectors such as mining, oil and gas, technology and drug discovery.
Upvote Downvote

 
Cynata Therapeutics talks stem cell research at Proactive's CEO Sessions

2017-03-06 proactiveinvestors.com.au
Cynata Therapeutics (ASX:CYP) is a stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™.
Upvote Downvote

 
Legend Mining brings Fraser Range nickel-copper hunt to Proactive's CEO Sessions

2017-03-06 proactiveinvestors.com.au
Legend Mining (ASX:LEG) is exploring on one of Australia's host post codes, the Fraser Range of Western Australia, with partner Creasy Group.
Upvote Downvote

 
Bluechiip Ltd sells biosample tracking kit to Chinese Ministry of Health

2016-08-01 proactiveinvestors.com.au
Bluechiip Ltd (ASX:BCT) has sold the first Bluechiip starter kit incorporating a tracking technology for biosamples, to the Chinese Centre for Disease, Control and Prevention (CCDC), based in Beijing. The CCDC is an agency of the Chinese Ministry of Health. The Bluechiip system provides temperature and identification tracking solutions for biosamples (any kind of tissue or body fluid). Bluechiip’s patented technology combines secure wireless sample tracking with integrated temperature reading for use in extreme environments, working in temperatures from -196°C to +200°C.
Upvote Downvote

 
Letter to Shareholders

2016-04-19 asx.com.au
Upvote Downvote

 

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

23h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...